ARDT Stock Analysis: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$9.18
0.15 (1.66%)
▲
5d:
-3.37%
30d:
-0.33%
90d:
+6.25%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARDT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ARDT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.58
Based on -35.6% avg growth
INTRINSIC VALUE TODAY
$0.36
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $9.18, which is considered fair relative to its 30-day fair value range of $8.79 to $9.70. The stock's valuation (Forward PE: 6.8) is in line with its historical norms (7.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARDT is showing sideways momentum. Immediate support is located at $8.76, while resistance sits at $9.78.
Market Sentiment: ARDT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.41 (+37.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARDT is showing sideways momentum. Immediate support is located at $8.76, while resistance sits at $9.78.
Market Sentiment: ARDT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.41 (+37.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.79 -
$9.70
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.4% below Wall St target ($12.41)
Trading Range Analysis
30-Day Trading Range
$8.79 -
$9.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$8.76
Resistance Level
$9.78
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.84
Wall Street Target
$12.41
(+37.4%)
Revenue Growth (YoY)
7.0%
Earnings Growth (YoY)
-3.4%
Profit Margin
2.1%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
6.8 vs 7.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$8.95
(-1%)
2-Year Target
$8.87
(-2%)
3-Year Target
$8.79
(-3%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
$8.99
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -75.2%)
$28.11
(+211%)
Base:
(SPY PE: 6.8, Growth: -75.2%)
$8.83
(-2%)
Bear:
(PE: 5.8, Growth: -75.2%)
$7.50
(-17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 9.48 | Current EPS (TTM): $0.94
Bull Case
$13.76
(+52%)
Analyst growth 40.4%, PE expands to 10.4
Base Case
$12.51
(+39%)
Market implied 40.4%, PE stable at 9.5
Bear Case
$6.06
(-33%)
Severe decline -20.0%, PE contracts to 8.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.8 to 7.0
Stabilization Target:
$9.24
(+2.3%)
PE Expansion Potential:
+2.3%
Share & Embed Analysis
Last updated: June 23, 2026 4:52 PM ET
Data refreshes hourly during market hours. Next update: 5:52 PM
Data refreshes hourly during market hours. Next update: 5:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
ARDT is a key holding in these high-performance investment strategies.
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
